Rebel Medicine is a preclinical-stage biopharmaceutical company developing non-opioid solutions for acute pain management. Our lead product candidate, ALEVATRIX, is a controlled-release local anesthetic formulation using a novel, proprietary delivery system. ALEVATRIX is designed to provide 72 hours of non-opioid pain relief through a single administration. Our unique formulation is a viscous gel that can be intuitively applied directly into surgical wounds or, due to its shear-thinning properties, it can be injected through the skin for nerve blocking applications. As surgery has become a gateway for opioid addiction and hospitals are in need of therapeutics which support faster recovery and time to discharge, our technology will provide value to the patient, society, and customer alike by increasing patient satisfaction, preventing opioid addiction, and reducing cost of care.